Loading clinical trials...
Loading clinical trials...
A Phase 1, Open Label, Fixed Sequence Design, Multiple Dose Study To Assess The Effect Of Rifampin On The Pharmacokinetics Of Sitaxsentan In Healthy Subjects
Conditions
Interventions
Sitaxsentan alone
Sitaxsentan
+1 more
Start Date
December 1, 2010
Primary Completion Date
January 1, 2011
Completion Date
January 1, 2011
Last Updated
March 5, 2015
NCT06649110
NCT07218029
NCT06481852
NCT01347216
NCT05464095
NCT06954727
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions